*The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (see
Withdrawal dates explained for more information).
DESCRIPTION This unit covers fundamental features and current methods involved in the medicinal chemistry and drug development process. The unit emphasises on lead identification, lead optimisation and the introduction of new drugs into clinical practice. It deals with specific case studies that examine real life drug discovery projects and how a range of drug design techniques are applied in each case and how the method used would impact on the success of the project(s). In addition, novel drug delivery systems (eg recombinant DNA technology, liposome) are also covered in detail.
WEIGHT:
12.5%
ASSESSMENT: 1-hr mid semester test (30%) and 1 x 2-hr exam (70%).
Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.
Campus - H Hobart, L Launceston, W Burnie. Study Centre - V Sydney, R Rozelle, P Beauty Point. Distance units may also have a campus identifier of I Isolated, N Interstate, O Overseas. Units delivered in Transnational Education (TNE) Programs have a campus identifier of A Hangzhou, F Fuzhou, G Shanghai, K KDU Malaysia, Q Kuwait or Y Hong Kong.
Special approval is required for enrolment into TNE Program units - campuses A, F, G, K, Q and Y click here for more information.